Network


Latest external collaboration on country level. Dive into details by clicking on the dots.

Hotspot


Dive into the research topics where William Bullock is active.

Publication


Featured researches published by William Bullock.


Synthetic Communications | 2004

A Concise Synthesis of N‐(1,3‐Thiazol‐2‐yl) Indoline‐5‐Sulfonic Acids and Sulfonyl Chlorides

Mingbao Zhang; Robert Dally; William Bullock

Abstract A general and practical synthetic method was developed for indoline‐5‐sulfonic acids bearing a thiazole heterocycle attached to the nitrogen atom. Two select sulfonic acids were further converted to their corresponding sulfonyl chlorides, key intermediates to the indoline‐5‐sulfonamide pharmacophore.


Bioorganic & Medicinal Chemistry Letters | 2004

In vitro SAR of (5-(2H)-isoxazolonyl) ureas, potent inhibitors of hormone-sensitive lipase.

Derek Lowe; Steven Magnuson; Ning Qi; Ann-Marie Campbell; James H. Cook; Zhenqiu Hong; Ming Wang; Furahi Achebe; Harold Kluender; Wai C. Wong; William Bullock; Arthur I. Salhanick; Terri Witman-Jones; Mary E. Bowling; Christine Keiper; Kevin B. Clairmont


Archive | 1996

2,2'-bridged bis-2,4-diaminoquinazolines

Rudolf Schohe-Loop; Peter-Rudolf Seidel; William Bullock; Walter Dr. Hübsch; Achim Feurer; Hans-Georg Lerchen; Georg Terstappen; Joachim Schuhmacher; Franz-Josef van der Staay; Bernard Schmidt; Richard J. Fanelli; Jane C. Chisholm; Richard T. McCarthy


Bioorganic & Medicinal Chemistry Letters | 2007

PDE-10A inhibitors as insulin secretagogues

Louis-David Cantin; Steven Magnuson; David E. Gunn; Nicole Barucci; Marina Breuhaus; William Bullock; Jennifer Burke; Thomas Claus; Michelle Daly; Lynn B. DeCarr; Ann Gore-Willse; Helana Hoover-Litty; Ellalahewage Kumarasinghe; Yaxin Li; Sidney X. Liang; James N. Livingston; Timothy B. Lowinger; Margit MacDougall; Herbert Ogutu; Alan Olague; Ronda Ott-Morgan; Robert W. Schoenleber; Adrian Tersteegen; Philip Wickens; Zhonghua Zhang; Jian Zhu; Lei Zhu; Laurel Sweet


Archive | 2002

Indane acetic acid derivatives and their use as pharmaceutical agents, intermediates, and method of preparation

Derek Lowe; Philip Wickens; Xin Ma; Mingbao Zhang; William Bullock; Philip Coish; Ingo A. Mugge; Andreas Stolle; Ming Wang; Yamin Wang; Chengzhi Zhang; Hai-Jun Zhang; Lei Zhu; Manami Tsutsumi; James N. Livingston


Archive | 2004

1,8-Naphthyridine derivatives and their use to treat diabetes and related disorders

Yamin Wang; William Bullock; David E. Gunn; Qingjie Liu; Sidney X. Liang; Donglei Liu; Steven Magnuson; Tindy Li; Eric S. Mull; Jill E. Wood; Ning Qi


Archive | 2002

1h-pyrazolyl derivative compounds, for use in diseases associated with the 5-ht2c receptor

Gaetan Ladouceur; Emil Velthuisen; Soongyu Choi; Yamin Wang; Jeremy L. Baryza; Phillip D. G. Coish; William Bullock; Roger A. Smith; Jinshan Chen


Archive | 2003

Anilinopyrazole derivatives useful for the treatment of diabetes

Joachim Rudolph; Louis-David Cantin; Steven Magnuson; William Bullock; Ann-Marie Bullion; Libing Chen; Chih-Yuan Chuang; Sidney X. Liang; Dyuti Majumdar; Herbert Ogutu; Alan Olague; Ning Qi; Philip Wickens


Archive | 2002

1, 8-naphthyridine derivatives as antidiabetics

Yamin Wang; David E. Gunn; Qingjie Liu; Sidney X. Liang; William Bullock; Donglei Liu; Steven Magnuson; Tindy Li; Eric S. Mull; Jill E. Wood; Ning Qi


Archive | 1996

Ring-bridged bis-quinolines

Rudolf Schohe-Loop; Peter-Rudolf Seidel; William Bullock; Achim Feurer; Georg Terstappen; Joachim Schuhmacher; Franz-Josef van der Staay; Bernard Schmidt; Richard J. Fanelli; Jane C. Chisholm; Richard T. McCarthy

Researchain Logo
Decentralizing Knowledge